Stay updated on Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Sign up to get notified when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.

Latest updates to the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page
- Check6 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3; no substantive changes to the study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the prior notices regarding government funding lapses and the earlier Revision: v3.4.1 as part of the site update.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now displays a government funding lapse notice banner and a site version update banner (Revision: v3.4.1). These are administrative changes and do not affect trial content, eligibility criteria, outcomes, or locations; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and updated several textual elements (e.g., capitalization of Last Update Submitted that Met QC Criteria and No FEAR Act Data) along with a revision label showing v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a consolidated Locations section listing study sites across Alabama, California, Colorado, Florida, Massachusetts, Michigan, New Jersey, New York, North Carolina, and Tennessee. Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure link and the previous v3.3.2 reference.SummaryDifference1%

Stay in the know with updates to Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.